实现低收入和中低收入国家的血友病诊疗可及性:世界血友病联盟扩展人道主义援助项目实施5年后的情况
本文报告世界血友病联盟(WFH)扩展人道主义援助项目(HAP)实施前5年(2015年中至2020年)的挑战与影响。捐赠凝血产品用于治疗超过25万次急性出血发作、管理约4000例手术,并在73个国家为约2000例患者建立出血预防性 prophylaxis。项目通过虚拟和面对面培训提升全球医护人员复杂需求患者的管理能力,部分政府因此增加血友病护理投资。
要点
- WFH HAP在73个国家捐赠凝血产品,治疗超过25万次急性出血发作。
- 项目支持约4000例手术管理,并为约2000例患者建立出血预防性 prophylaxis。
- 部分政府响应项目增加血友病护理投资,包括独立采购少量治疗产品。
核心结论
- WFH HAP规模与复杂度空前,为血友病患者及社会带来实质性获益,是营利与非营利组织合作推进LICs和LMICs医疗公平的典范,可被其他支持不同单基因疾病的组织复制。
研究设计与样本
- 报告世界血友病联盟(WFH)扩展人道主义援助项目(HAP)实施前5年(2015年中至2020年)的挑战与影响。
主要发现
- WFH HAP捐赠的凝血产品在73个国家用于治疗超过25万次急性出血发作、管理约4000例手术,并为约2000例患者建立出血预防性 prophylaxis。
- 全球医护人员通过虚拟和面对面培训学习复杂需求患者的最佳管理。
- 部分政府响应项目增加血友病护理投资,包括独立采购少量治疗产品。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Highly effective treatment of haemophilia A and B is primarily available to 15% of the world's population, in high-income countries. In low-income countries (LICs) and lower-middle-income countries (LMICs), morbidity and mortality are high because of greatly reduced access to diagnosis, care, and treatment. We report the challenges and impact after the first 5 years (mid-2015-2020) of the expanded World Federation of Hemophilia (WFH) Humanitarian Aid Program (HAP). WFH HAP donated coagulation products were used to treat more than 250 000 acute bleeding episodes, manage approximately 4000 surgeries, and establish bleeding preventive prophylaxis in about 2000 patients in 73 countries. Health-care providers worldwide learned optimal management of patients with complex needs through virtual and in-person training. In response to the programme, some governments increased investment in haemophilia care, including independent purchases of small amounts of treatment products. With unparalleled scope and complexity, and substantial benefits to people with haemophilia and society in general, the WFH HAP is an exemplar of partnership between for-profit and not-for-profit organisations advancing health-care equity in LICs and LMICs, which could be replicated by other organisations supporting people with different monogenic diseases.
引用
- Pierce GF, Adediran M, Diop S, et al. Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years. Lancet Haematol. 2022. PMID: 36055333. doi:10.1016/S2352-3026(22)00209-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。